• Mashup Score: 14
    CMS-Will-Cover-80-Of-Leqembi-Cost-No-Trial-Entry-Needed - 9 month(s) ago

    With-the-FDA-having-granted-full-traditional-approval-to-the-anti-amyloid-Alzheimer-rsquo-s-disease-drug-lecanemab-irmb-in-July-and-CMS-confirming-that-it-will-cover-80-of-the-medication-rsquo-s-cost-without-requiring-participation-in-a-randomized-clinical-trial-the-landscape-of-AD-treatment-in-the-United-States-is-about-to-look-very-different

    Source: www.specialtypharmacycontinuum.com
    Categories: Healthcare Professionals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of DrFerdowsi
      DrFerdowsi

      RT @LEAD_Coalition: #Medicare Will Cover 80% Of #Alzheimers treatment #Leqembi Cost; No Trial Entry Needed https://t.co/2iuxpf3sXd #demen…

  • Mashup Score: 1
    Digital Rx Ripe For Widespread COVID-19 Use - 4 year(s) ago

    Digital therapeutics that deliver evidence-based interventions to help prevent, manage or treat medical conditions can play an even more important role during the COVID-19 pandemic, when people are staying at home and not necessarily seeing their providers regularly, according to several AMCP webinar presentations.

    Source: www.specialtypharmacycontinuum.com
    Categories: Latest Headlines, Payer
    Tweet Tweets with this article
    • Profile photo of amcporg
      amcporg

      RT @SpecialtyPharm: AMCP Webinar: Digital Rx ripe for widespread COVID-19 use. https://t.co/Lo7mqzCBXd @amcporg @CVSHealth @PattyPharmD @We…

  • Mashup Score: 0
    Getting Patients the Medications They Need - 4 year(s) ago

    Medicines that might aid in the fight against COVID-19 are flooding our newsfeeds. As health care researchers around the world seek treatments and vaccines, the health care system must be ready to identify those therapies that demonstrate the greatest value and expedite them to patients as quickly as possible.

    Source: www.specialtypharmacycontinuum.com
    Categories: Latest Headlines, Payer
    Tweet Tweets with this article
    • Profile photo of amcporg
      amcporg

      “The current situation with #COVID19 offers a clear example of why sharing early information on medications in the pipeline is important,“ says @amcpceo. Read her insights about pharmaceutical info exchange in @SpecialtyPharm: https://t.co/bHx1xfZxEW

  • Mashup Score: 0
    Community Cancer Care Adapts to COVID-19 - 4 year(s) ago

    When it comes to delivering cancer care amid the COVID-19 pandemic, it takes a village: Pharmacy benefit managers, Pharma, providers and clinic directors all are pulling together to ensure adequate access despite social distancing and other unprecedented pressures, experts noted during an April 3 webinar.

    Source: www.specialtypharmacycontinuum.com
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of TedOkonCOA
      TedOkonCOA

      Community Cancer Care Adapts to COVID-19 via @SpecialtyPharm “We can shut down the country, but we can’t shut down cancer,” said Ted Okon, the executive director of the Community Oncology Alliance (COA). @oncologyCOA https://t.co/DLuJnKuaiY